SVS-1 peptide acetate, an amphipathic β-hairpin anticancer peptide, leverages tumor-selective electrostatic binding to rapidly disrupt malignant cell membranes. Featuring synthetic handles for bioconjugation, it’s ideal for ADC development, targeted drug delivery and membrane-perturbation studies.
Usually ships within 24 hours.